Zetiq has developed a unique proprietary platform CellDetect® technology, for the detection of cancer cells via discriminate staining of cancer cells among normal cells, while preserving the morphological features of the cells.
Our unique platform technology enables color discrimination between red cancer cells and green non cancer cells. Using a simple in-vitro procedure to stain cells we offer dual color and morphological diagnostic products that are resource saving and amendable to automation, in a wide range of cancer indications.
Products originating from the platform CellDetect® Technology have achieved positive results in targeted clinical trials, and Zetiq intends to expand development of products of the CellDetect® Technology towards the high market value of cancer diagnosis.
